Imprimed
Provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD155—233m (Dealroom.co estimates Nov 2023.)
Company register number 6668701227
Palo Alto California (HQ)
Financials
Estimates*
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 2.6m | 3.1m |
| % growth | - | 19 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$300k | Seed | ||
N/A | Seed | ||
$3.7m | Seed | ||
$7.7m | Early VC | ||
| N/A | $300k | Grant | |
* | N/A | Seed | |
* | KRW30.0b | Series A | |
| Total Funding | AUD57.4m | ||
Related Content
Recent News about Imprimed
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.